Cyclin-Dependent Kinase Inhibitor 2A/B Homozygous Deletion Prediction and Survival Analysis

Cyclin-Dependent Kinase Inhibitor 2A/B (CDKN2A/B) homozygous deletion was a significant prognostic factor for gliomas and affected the treatment strategy. However, the radiomic features of CDKN2A/B homozygous deletion in gliomas have not been developed, and whether the radiomic features and molecula...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Jing, Li, Lei, Luo, Tao, Nie, Chengsong, Fan, Rui, Li, Deqiang, Yang, Rui, Zhou, Changru, Li, Qian, Hu, Xiaofei, Chen, Wei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10136851/
https://www.ncbi.nlm.nih.gov/pubmed/37190513
http://dx.doi.org/10.3390/brainsci13040548

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10136851/
https://www.ncbi.nlm.nih.gov/pubmed/37190513
http://dx.doi.org/10.3390/brainsci13040548

Ejemplares similares